Allergy/Imm Medical News about Biomaterials

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition
Trends in Immunology, 10/27/09

Nilsson B et al. – Such treatments are associated with anaphylactoid and thrombotic reactions, inflammation, and rejection of biomaterials and cells, leading to treatment failures and adverse reactions. The authors discuss here the new technologies that are being developed to shield the biomaterial and cell surfaces from recognition by the innate immune system.

<< Previous
Monocytes and [gamma][delta] T cells: close encounters in...

Next >>
The need to identify myeloid dendritic cell progenitors in human...

Development of a new chitosan hydrogel for wound dressing
Wound Repair and Regeneration, 11/13/09 Relevance Score: 84%

Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09 Relevance Score: 80%

Structural Augmentation with Biomaterial-Loaded Allograft Threaded Cage for the Treatment of Femoral Head Osteonecrosis
Journal of Arthroplasty, 10/21/09 Relevance Score: 80%

Biomaterial optimization in a percutaneous aortic valve stent using finite element analysis
Cardiovascular Revascularization Medicine, 10/16/09 Relevance Score: 80%

Rejection of Permacol mesh used in abdominal wall repair: A case report
World Journal of Gastroenterology, 10/01/09 Relevance Score: 80%